Skip to content

Australia shows an alternative to rationing hepatitis C treatment

France to provide universal access to hepatitis C treatment

Low-cost generic hepatitis C drugs match branded products in viral response

Dr James Freeman presenting at ILC 2016. Photo by Liz Highleyman, hivandhepatitis.com

$300 hepatitis C combination to enter clinical trials

Indian study proves that more people virally suppressed in a population equals fewer HIV infections

PopART trial shows feasibility of reaching 90-90-90 targets for testing and treatment coverage in Zambia and South Africa

Community HIV care providers (CHiPs) delivering home-based HIV testing. Photo by Frank Herholdt, thanks to Imperial College London.

African Americans have highest HIV incidence, lowest rate of consistent care

New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

UK maintains the largest HIV epidemic in western Europe